Invesco
ABCL icon

Invesco’s AbCellera Biologics ABCL Stock Holding History

Invesco’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
49,753
-10,642
-18% -$52K ﹤0.01% 3340
2026
Q1 		$211K Buy
60,395
+5,792
+11% +$20.8K ﹤0.01% 3467
2025
Q4 		$187K Buy
54,603
+11,914
+28% +$53.2K ﹤0.01% 3546
2025
Q3 		$215K Buy
42,689
+5,577
+15% +$24.6K ﹤0.01% 3545
2025
Q2 		$127K Buy
37,112
+12,966
+54% +$32.3K ﹤0.01% 3616
2025
Q1 		$53.8K Buy
24,146
+12,893
+115% +$37K ﹤0.01% 3690
2024
Q4 		$33K Buy
11,253
+303
+3% +$844 ﹤0.01% 3722
2024
Q3 		$28.5K Sell
10,950
-2,793
-20% -$7.74K ﹤0.01% 3731
2024
Q2 		$40.7K Buy
13,743
+2,315
+20% +$8.76K ﹤0.01% 3836
2024
Q1 		$51.8K Buy
+11,428
New +$58.3K ﹤0.01% 3798
2023
Q2 		– Sell
-95,208
Closed -$718K – 3859
2023
Q1 		$718K Buy
95,208
+17,017
+22% +$155K ﹤0.01% 3075
2022
Q4 		$792K Sell
78,191
-3,863
-5% -$44.6K ﹤0.01% 3035
2022
Q3 		$812K Buy
82,054
+4,695
+6% +$51.5K ﹤0.01% 3004
2022
Q2 		$824K Buy
+77,359
New +$655K ﹤0.01% 3077
2021
Q4 		– Sell
-28,110
Closed -$563K – 4025
2021
Q3 		$563K Buy
28,110
+13,854
+97% +$245K ﹤0.01% 3375
2021
Q2 		$314K Buy
+14,256
New +$393K ﹤0.01% 3610

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Invesco's ABCL Position: Q2 2026 in Review

Invesco reduced its AbCellera Biologics (ABCL) stake by 18% in Q2 2026, selling an estimated $52K and leaving 49,753 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #3340.

Invesco first reported a position in ABCL in Q2 2021 and has held it in 16 quarters since. The position peaked at $824K in Q2 2022. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Invesco held 49,753 shares of AbCellera Biologics worth $391K as of Q2 2026.
  • Invesco sold 10,642 AbCellera Biologics shares in Q2 2026, an estimated $52K.
  • AbCellera Biologics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3340 holding.
  • Invesco first reported a position in AbCellera Biologics in Q2 2021 and has held it in 16 quarters since.
  • Invesco's AbCellera Biologics position peaked at $824K in Q2 2022.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.